Newer Drugs to Reduce High Blood Pressure and Mitigate Hypertensive Target Organ Damage-Reference-Cited by-同舟云学术

Newer Drugs to Reduce High Blood Pressure and Mitigate Hypertensive Target Organ Damage

Published:2022-01 Issue:1 Volume:24 Page:1-20
ISSN:1522-6417
Container-title:Current Hypertension Reports
language:en
Short-container-title:Curr Hypertens Rep

Author:

Upadhya Bharathi,Kozak Patrick M.,Stacey Richard Brandon,Vasan Ramachandran S.

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11906-022-01166-9.pdf

Reference91 articles.

1. World Health Organization Global Health Observatory (GHO) data. Available from: https://www.who.int/gho/mortality_burden_disease/life_tables/situation_trends_text/en

2. Nwabuo CC, Vasan RS. Pathophysiology of hypertensive heart disease: beyond left ventricular hypertrophy. Curr Hypertens Rep. 2020;22:11.

3. Drazner MH. The progression of hypertensive heart disease. Circulation. 2011;123:327–34.

4. Messerli FH, Rimoldi SF, Bangalore S. The transition from hypertension to heart failure: contemporary update. JACC Heart Fail. 2017;5:543–51.

5. Brooks JE, Soliman EZ, Upadhya B. Is left ventricular hypertrophy a valid therapeutic target? Curr Hypertens Rep. 2019;21:47.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The alleviative effects of canagliflozin on imiquimod-induced mouse model of psoriasis-like inflammation;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-09-10

2. Efficacy of Huoxue Qianyang Qutan Recipe on essential hypertension: A randomized, double-blind, placebo-controlled trial;Journal of Integrative Medicine;2024-07

3. Soybean-derived antihypertensive hydrolysates attenuate Ang II-induced renal damage by modulating MAPK and NF-κB signaling pathways;Food & Function;2024

4. Preventing new-onset heart failure: Intervening at stage A;American Journal of Preventive Cardiology;2023-12

5. Efficacy and safety evaluation of SGLT2i on blood pressure control in patients with type 2 diabetes and hypertension: a new meta-analysis;Diabetology & Metabolic Syndrome;2023-06-07